SEHK:1681Pharmaceuticals
Consun Pharmaceutical Group (SEHK:1681) Lifts Earnings And Dividend On A Valuation That Still Looks Cheap
Consun Pharmaceutical Group (SEHK:1681) has drawn investor attention after reporting half year 2026 results along with an interim dividend announcement. The combination of earnings detail and cash distribution timing gives you fresh information to assess the stock.
Against this backdrop, Consun Pharmaceutical Group’s share price has softened, with a 7 day share price return of down 8.84% and a year to date share price return of down 12.48%. The 3 year total shareholder return of 231.95%...